Walk the independent claim. Ten3T Healthcare's grant US11284806B2, "Method and system for cardiac health monitoring" (issued March 29, 2022; inventors Rahul Shingrani and Sudhir Borgonha), is a granted patent. Its CPC mix — A61B 5/02438 for cardiovascular PPG, A61B 5/24 for bioelectric sensing, A61B 5/681 for body-worn devices — marks a multi-modal clinical cardiac monitor.
The element that does the work is continuous, clinical-grade monitoring on the body. A Holter monitor records cardiac activity over hours or days from a clinic-issued device; the claim covers a wearable doing the equivalent continuous monitoring with the modality combination clinical use requires. That is the diagnostic bar moving from a dedicated medical device onto a wearable.
What it reads on is a clinical cardiac-monitoring wearable — a patch or band used for extended heart monitoring, the category between a consumer watch and a hospital monitor. Ten3T operates in exactly that clinical-wearable space, and the claim protects the continuous-monitoring method its products perform.
The distinction the desk insists on — consumer wellness versus clinical monitoring — is the crux. A watch that occasionally checks heart rate is wellness; a device claimed for continuous cardiac health monitoring with multi-modal sensing is reaching toward the clinical category, with its heavier regulatory and IP stakes. Reading the claim precisely keeps that line visible.
Scope discipline: the claim protects the recited monitoring method and system, not cardiac sensing generally. A consumer wearable lacking the recited continuous multi-modal monitoring operates outside it. The defensible element is the continuous clinical-monitoring method as claimed.
For a strategist, US11284806B2 is one more marker that the wearable-health frontier runs through the clinical-monitoring category — where smaller specialized firms, not just the platform giants, hold granted, enforceable IP. The competitive map there is broader than the consumer-watch headlines suggest.